Image

Effects of Staged Adapted Inclusions in Infant Cereals on Oral-motors Patterns of 6-24 Month-old Children

Effects of Staged Adapted Inclusions in Infant Cereals on Oral-motors Patterns of 6-24 Month-old Children

Recruiting
6-6 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to define the effects of different inclusions in infant cereals on the adaptation of oral motor behavior and skills displayed at a given age.

Eligibility

Inclusion Criteria:

  1. Children between 6 months (182 days) to 24 months (730 days) of age (from enrollment to last visit):

    1.1. \[182-242\]-days of age from V1 to last visit for the 6-8-month-old age group 1.2. \[243-364\]-days of age from V1 to last visit for the 8-12-month-old age group 1.3. \[365-547\]-days of age from V1 to last visit for the 12-18-month-old age group 1.4. \[548-730\]-days of age from V1 to last visit for the 18-24-month-old age group

  2. Singleton, full-term infants (≥ 37 completed weeks of gestation), with a birth weight of ≥ 2.5 kg and ≤ 4.5 kg.
  3. Healthy children based on medical history as reported by parent(s) / LAR(s).
  4. Sit upright with or without support (such as, sitting with back against a chair or while being held) as reported by parent(s) / LAR(s)
  5. Keep head steady when in a supported position
  6. Have already started complementary feeding as recommended by their health care professional (have started solid food beyond breastmilk or infant formula)
  7. Written informed consent is obtained from at least one parent(s) / LAR(s).
  8. Parent(s) / LAR(s) must be able to provide evidence of parental authority and identity.
  9. Parent(s) / LAR(s) must understand the informed consent and other study documents.
  10. Parent(s) / LAR(s) are willing and able to fulfill the requirements of the study protocol within the study timeframe.

Exclusion Criteria:

  • 1\. Infant's parents or LARs have not reached legal age of majority (18 years) 2. Children with history of oral/facial malformations or surgery (i.e. cleft lip, cleft palate, tongue-tie/ankyloglossia), or history of tube feeding for any reason.

    3\. Children with any chronic illness, congenital malformations (e.g., esophageal or intestinal atresia), surgical sequela (e.g., short bowel syndrome), gastroesophageal reflux disease, behavioral disorders, neurodevelopmental delay or illness that impacts feeding. \[children with an acute illness, such as a cold, gastroenteritis etc. can be included but can only attend the visits once they have recovered\].

    4\. Children with feeding or swallowing difficulties/disorders, history of choking, or at high risk of choking.

    5\. Child or sibling(s) who has known or suspected food allergy or intolerance, such as cows' milk protein allergy, celiac disease, lactose intolerance, soy allergy, fish allergy, or any other suspected or confirmed food allergies or intolerance.

    6\. Children with undernutrition as determined by age-group weight threshold (based on parental reports): weight at \[6-8\[month \< 6 kg; weight at \[8-12\[months: \< 6.5 kg; weight at \[12-18\[months: \< 7.5 kg; weight at \[18-24\] months: \< 8.5 kg.

    7\. Child is currently participating in or has participated in another intervention clinical study that impacts study outcomes within 4 weeks prior to enrolment or has participated in another age group of this study.

    8\. Family or hierarchical relationships with the research team members.

Study details
    Healthy
    Infant and Young Child Feeding

NCT07318506

Société des Produits Nestlé (SPN)

15 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.